UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Biomarkers and biomarker validation: a pathologist's guide to getting it right

Pathology, 2024-03, Vol.56 (2), p.147-157

2024

Link zum Volltext

Verfügbarkeit prüfen

Metastatic progression of breast cancer: insights from 50 years of autopsies

The Journal of pathology, 2014-01, Vol.232 (1), p.23-31

2014

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4701-4708

2009

Link zum Volltext

Verfügbarkeit prüfen

Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction

PloS one, 2011-10, Vol.6 (10), p.e26088

2011

Link zum Volltext

Verfügbarkeit prüfen

ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia

Pathology, 2019-06, Vol.51 (4), p.345-348

2019

Link zum Volltext

Verfügbarkeit prüfen

Angiolipoma: A Unique Cause of Carpal Tunnel Syndrome

Case reports in orthopedic research, 2021-01, Vol.4 (1), p.24-28

2021

Link zum Volltext

Verfügbarkeit prüfen

Mapping of anatomical pathologist workload via epic beaker flag function

Pathology, 2024-02, Vol.56, p.S67

2024

Link zum Volltext

Verfügbarkeit prüfen

Are we overFISHing? Immunohistochemistry as a screening tool for FISH testing for MYC rearrangement in high grade B cell lymphomas

Pathology, 2024-02, Vol.56, p.S58

2024

Link zum Volltext

Verfügbarkeit prüfen

Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer

Pathology, 2014-08, Vol.46 (5), p.383-388

2014

Link zum Volltext

Verfügbarkeit prüfen

Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer

Gastroenterology (New York, N.Y. 1943), 2009-08, Vol.137 (2), p.558-568.e11

2009

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation

Pathology, 2009-01, Vol.41 (4), p.383-387

2009

Link zum Volltext

Verfügbarkeit prüfen

Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort

Translational lung cancer research, 2019-04, Vol.8 (2), p.167-175

2019

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease

BMC cancer, 2012-11, Vol.12 (1), p.555-555, Article 555

2012

Link zum Volltext

Verfügbarkeit prüfen

Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program

Pathology, 2016-10, Vol.48 (6), p.535-542

2016

Link zum Volltext

Verfügbarkeit prüfen

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

Journal of clinical oncology, 2002-12, Vol.20 (23), p.4531-4542

2002

Link zum Volltext

Verfügbarkeit prüfen

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program

Breast cancer research and treatment, 2012-07, Vol.134 (2), p.617-624

2012

Link zum Volltext

Verfügbarkeit prüfen

High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype

Histopathology, 2010-02, Vol.56 (3), p.286-296

2010

Link zum Volltext

Verfügbarkeit prüfen

Intraosseous Lipomatous Meningioma

Case reports in neurological medicine, 2015-01, Vol.2015, p.482140-3

2015

Link zum Volltext

Verfügbarkeit prüfen

Primary synovial chondromatosis in the skull base

Otology & neurotology, 2011-04, Vol.32 (3), p.e20

2011

Link zum Volltext

Verfügbarkeit prüfen

Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33

Pathology, 2013-12, Vol.45 (7), p.629-636

2013

Link zum Volltext

Verfügbarkeit prüfen

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status

International journal of cancer, 2010-03, Vol.126 (6), p.1445-1453

2010

Link zum Volltext

Verfügbarkeit prüfen

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

Pathology, 2006-04, Vol.38 (2), p.120-124

2006

Link zum Volltext

Verfügbarkeit prüfen

Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification

Clinical cancer research, 2008-10, Vol.14 (20), p.6625-6633

2008

Link zum Volltext

Verfügbarkeit prüfen

Xanthomatous pituitary lesions: a report of two cases and review of the literature

Pituitary, 2003, Vol.6 (3), p.161-168

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(50)
Humans
(48)
Female
(28)
Pathology
(23)
Immunohistochemistry
(19)
Biological And Medical Sciences
(18)
Male
(18)
Aged
(16)
Medical Sciences
(16)
Adult
(15)
Middle Aged
(15)
Oncology
(15)
Breast Cancer
(14)
Tumors
(14)
In Situ Hybridization, Fluorescence
(11)
Breast Neoplasms - Genetics
(9)
Breast Neoplasms - Metabolism
(9)
Receptor, Erbb-2 - Genetics
(9)
Receptor, Erbb-2 - Metabolism
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarkers and biomarker validation: a pathologist's guide to getting it right

Metastatic progression of breast cancer: insights from 50 years of autopsies

Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel

Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction

Clinical and molecular characterization of HER2 amplified-pancreatic cancer

ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia

Angiolipoma: A Unique Cause of Carpal Tunnel Syndrome

Mapping of anatomical pathologist workload via epic beaker flag function

Are we overFISHing? Immunohistochemistry as a screening tool for FISH testing for MYC rearrangement in high grade B cell lymphomas

Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer

Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer

Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation

Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease

Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program

High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype

Intraosseous Lipomatous Meningioma

Primary synovial chondromatosis in the skull base

Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification

Xanthomatous pituitary lesions: a report of two cases and review of the literature

Suchergebnisse filtern